2022
Novo Holdings acquires The Ritedose Corporation and fully automated packaging lines increased to six
Stability & Regulatory Support
ICH Stability program to support semipermeable conditions. Regulatory team supports project throughout regulatory lifecycle.
Analytical & Microbiology Support
Dedicated multidisciplinary team to support all aspects of development from method development, method validation, sterility & bioburden along with our robust microbiology lab.
Process Development & Technology Transfer
Development engineering teams lead all aspects of product development/transfers from the clinical study stage and manage projects throughout the development lifecycle, process validation & commercial launch.
2016
TRC obtains fourth ANDA and operating capacity reaches 2.1 billion units with 10 BFS machines, five fully automated packaging lines and one semi-automated packaging line
- 1
- 2
Recent Posts
- Ritedose Meets Workforce Demand with RISE Program Partnership with InSpring and Benedict College
- Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*
- Ritedose Pharmaceuticals Continues Tradition of Giving Back – Increases its Annual Donation to Unprecedented Amount of 1 Million Doses of Respiratory Medications to Dispensary of Hope for Low-income and Chronically lll Patients
- Ritedose Named Top 2023 Fundraiser by the American Heart Association
- Ritedose Interns Volunteer for Food Distribution at State’s Largest Food Bank, Harvest Hope
Archives
Categories
Recent News
-
Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)* Posted on 16th September, 2024
Post Categories
- In the News (13)
- Press Releases (13)
- Uncategorized (18)
Recent Comments